Simon Quick Advisors’s DexCom DXCM Stock Holding History

Simon Quick Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-20	Closed	-$749	–	407
2019 Q2	$749	Buy	+20	New	+$629	﹤0.01%	436

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Simon Quick Advisors's DXCM Position: Q3 2019 in Review

Simon Quick Advisors sold out of DexCom (DXCM) in Q3 2019, closing a stake of 20 shares — an estimated $749 sold.

Simon Quick Advisors first reported a position in DXCM in Q2 2019 and held it in 1 quarter. The position peaked at $749 in Q2 2019. 424 funds tracked by Wall St. Rank hold DXCM as of Q3 2019.

Simon Quick Advisors reported no remaining DexCom position as of Q3 2019 after selling out during the quarter.
Simon Quick Advisors sold 20 DexCom shares in Q3 2019, an estimated $749.
Simon Quick Advisors first reported a position in DexCom in Q2 2019 and held it in 1 quarter.
Simon Quick Advisors's DexCom position peaked at $749 in Q2 2019.
424 funds tracked by Wall St. Rank held DexCom as of Q3 2019.

Based on Simon Quick Advisors's 13F filing for Q3 2019, filed 16 Oct 2019.